NAMA CRO was established in 2023 as a Saudi CRO ,and expanded in 2024 to be a regional CRO specialized in clinical trials management and BE, we partner with pharmaceutical, biotechnology, and medical device companies to accelerate the development of new treatments and products. NAMA CRO manages the planning, execution, and monitoring of clinical trials, helping our clients navigate complex regulatory requirements and ensure the safety and efficacy of their products. We play a crucial role in reducing time-to-market and optimizing costs. At the core of our CRO’s services is a commitment to quality, compliance, and efficiency.
Company Details
- Employees
- 4
- Founded
- -
- Address
- Riyadh, Sa
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- https://nama.med.sa
- Keywords
- Clinical Trials Phase I-IV, Bioequivalence, Medical Writing, Biomatrics, Data Management, Biostatistics, Quality Consultations, Training.
- HQ
- Riyadh
Nama Cro Questions
Nama Cro's website is https://nama.med.sa
Nama Cro's LinkedIn profile is https://sa.linkedin.com/company/namacro
Nama Cro has
4 employees.
View email and phone details for 4
employees at Nama Cro.
Nama Cro's industry is
Research Services
Nama Cro's top competitors are
Waraqa Publishing House,
Medark Cro,
Integra,
Trillium Sciences,
Nala Health,
Pdc Cro,
Hevolution Foundation,
Marc,
المعهد الوطني لأبحاث الصحة | Saudi Nih,
Integrative Health.
Nama Cro's categories are Research Services
Nama Cro's founding year is 2023
